Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
Minhong Shen(Fudan University Shanghai Cancer Center), Yibin Kang(Rutgers, The State University of New Jersey), Michelle Rowicki(Princeton University), Xinlei Sheng(Princeton University), Lanjing Zhang(Rutgers, The State University of New Jersey), Jooeun Kang(Virginia Commonwealth University), Hanqiu Zheng(Shanxi Medical University), Yong Wei(The Ohio State University), Toni Celià-Terrassa(Princeton University), Mark Esposito(Princeton University), Yi‐Rong Liu(Shanghai Medical College of Fudan University), Zhi-Ming Shao(Fudan University Shanghai Cancer Center), Yi-Zhou Jiang(Shanghai Medical College of Fudan University), Weichung Shih(Rutgers, The State University of New Jersey), Brian Ell(Princeton University), Xiang Hang(Christian-Albrechts-Universität zu Kiel), IIeana Cristea(Princeton University)
Cited by 217
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k